@michaelcoyote - indeed; she can write her own ticket now. Since 2019 was senior vice president of BioNTech RNA Pharmaceuticals, but in 2022 she left BioNTech to devote more time to research. So she obviously still wants to do research.
Top-level
@michaelcoyote - indeed; she can write her own ticket now. Since 2019 was senior vice president of BioNTech RNA Pharmaceuticals, but in 2022 she left BioNTech to devote more time to research. So she obviously still wants to do research. 1 comment
|
@johncarlosbaez Yes it seems so based on everything I've read about her.